Preclinical combination therapy of the investigational drug NAMI-A+ with doxorubicin for mammary cancer
Crossref DOI link: https://doi.org/10.1007/s10637-014-0175-5
Published Online: 2014-10-23
Published Print: 2015-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bergamo, Alberta
Riedel, Tina
Dyson, Paul J.
Sava, Gianni
Text and Data Mining valid from 2014-10-23
Version of Record valid from 2014-10-23
Article History
Received: 4 June 2014
Accepted: 9 October 2014
First Online: 23 October 2014